Akkina R - Search Results

1

Current status of gene therapy strategies to treat HIV/AIDS.

Strayer DS, Akkina R, Bunnell BA, Dropulic B, Planelles V, Pomerantz RJ, Rossi JJ, Zaia JA. Strayer DS, et al. Among authors: akkina r. Mol Ther. 2005 Jun;11(6):823-42. doi: 10.1016/j.ymthe.2005.01.020. Mol Ther. 2005. PMID: 15922953 Free article. Review.

2

Zika virus induced microcephaly and aberrant hematopoietic cell differentiation modeled in novel neonatal humanized mice.

Schmitt K, Curlin JZ, Remling-Mulder L, Aboellail T, Akkina R. Schmitt K, et al. Among authors: akkina r. Front Immunol. 2023 Feb 7;14:1060959. doi: 10.3389/fimmu.2023.1060959. eCollection 2023. Front Immunol. 2023. PMID: 36825016 Free PMC article.

3

High-efficiency gene transfer into CD34+ cells with a human immunodeficiency virus type 1-based retroviral vector pseudotyped with vesicular stomatitis virus envelope glycoprotein G.

Akkina RK, Walton RM, Chen ML, Li QX, Planelles V, Chen IS. Akkina RK, et al. J Virol. 1996 Apr;70(4):2581-5. doi: 10.1128/JVI.70.4.2581-2585.1996. J Virol. 1996. PMID: 8642689 Free PMC article.

4

Characterization of anti-CCR5 ribozyme-transduced CD34+ hematopoietic progenitor cells in vitro and in a SCID-hu mouse model in vivo.

Bai J, Gorantla S, Banda N, Cagnon L, Rossi J, Akkina R. Bai J, et al. Among authors: akkina r. Mol Ther. 2000 Mar;1(3):244-54. doi: 10.1006/mthe.2000.0038. Mol Ther. 2000. PMID: 10933940 Free article.

5

Multivalent anti-CCR ribozymes for stem cell-based HIV type 1 gene therapy.

Bai J, Rossi J, Akkina R. Bai J, et al. Among authors: akkina r. AIDS Res Hum Retroviruses. 2001 Mar 20;17(5):385-99. doi: 10.1089/088922201750102427. AIDS Res Hum Retroviruses. 2001. PMID: 11282007

6

Development of an Rev-independent, minimal simian immunodeficiency virus-derived vector system.

Pandya S, Boris-Lawrie K, Leung NJ, Akkina R, Planelles V. Pandya S, et al. Among authors: akkina r. Hum Gene Ther. 2001 May 1;12(7):847-57. doi: 10.1089/104303401750148847. Hum Gene Ther. 2001. PMID: 11339901

7

RNA-based anti-HIV-1 gene therapeutic constructs in SCID-hu mouse model.

Bai J, Banda N, Lee NS, Rossi J, Akkina R. Bai J, et al. Among authors: akkina r. Mol Ther. 2002 Dec;6(6):770-82. doi: 10.1006/mthe.2002.0800. Mol Ther. 2002. PMID: 12498773 Free article.

8

Inhibition of HIV-1 by lentiviral vector-transduced siRNAs in T lymphocytes differentiated in SCID-hu mice and CD34+ progenitor cell-derived macrophages.

Banerjea A, Li MJ, Bauer G, Remling L, Lee NS, Rossi J, Akkina R. Banerjea A, et al. Among authors: akkina r. Mol Ther. 2003 Jul;8(1):62-71. doi: 10.1016/s1525-0016(03)00140-0. Mol Ther. 2003. PMID: 12842429 Free article.

9

siRNAs, ribozymes and RNA decoys in modeling stem cell-based gene therapy for HIV/AIDS.

Akkina R, Banerjea A, Bai J, Anderson J, Li MJ, Rossi J. Akkina R, et al. Anticancer Res. 2003 May-Jun;23(3A):1997-2005. Anticancer Res. 2003. PMID: 12894572 Review.

10

Potent suppression of HIV type 1 infection by a short hairpin anti-CXCR4 siRNA.

Anderson J, Banerjea A, Planelles V, Akkina R. Anderson J, et al. Among authors: akkina r. AIDS Res Hum Retroviruses. 2003 Aug;19(8):699-706. doi: 10.1089/088922203322280928. AIDS Res Hum Retroviruses. 2003. PMID: 13678472

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

101 results

Search Page

Filters